Lawsuit On Sale Of Investigational Drugs Divides Oncology Community
Executive Summary
Allowing patients to buy investigational drugs would undermine FDA's clinical trial system, medical groups contend in a pair of amicus briefs seeking to reverse an appeals court ruling